Who owns Alnylam Pharmaceuticals?

Key details on Alnylam Pharmaceuticals (Ticker: ALNY)

Who owns Alnylam Pharmaceuticals?

Is ALNY a good stock to own? Find out who bought Alnylam Pharmaceuticals, who sold Alnylam Pharmaceuticals (ALNY) stock, and who holds a large position in Alnylam Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
FMR 12.56M $1.31B March 31, 2015
Wellington Management Company 10.44M $1.09B March 31, 2015
Vanguard 4.33M $451.97M March 31, 2015
Capital World Investors^ 2.14M $223.32M March 31, 2015
Columbia Wanger Asset Management 1.91M $122.87M Dec. 31, 2013
HealthCor Management 1.80M $16.87M June 30, 2011
UBS GLOBAL ASSET MANAGEMENT AMERICAS 1.77M $185.34M March 31, 2015
BlackRock Institutional Trust Company, N.A. 1.76M $183.71M March 31, 2015
BlackRock Fund Advisors 1.69M $176.74M March 31, 2015
Schroder Investment Management 1.64M $105.18M Sept. 30, 2013
Gilder, Gagnon, Howe & Co 1.51M $180.55M June 30, 2015
HealthCor Management 1.45M $35.34M March 31, 2013
MORGAN STANLEY 1.38M $133.51M Dec. 31, 2014
Falcon Edge Capital 1.37M $132.67M Dec. 31, 2014
Bridger Management 1.37M $33.31M March 31, 2013
Camber Capital Management 1.28M $14.17M March 31, 2012
T. Rowe Price Associates 1.26M $131.74M March 31, 2015
First Trust Advisors 1.25M $131.00M March 31, 2015
Deerfield Management Company 1.22M $29.77M March 31, 2013
CITADEL ADVISORS 1.19M $36.84M June 30, 2013
STATE STREET CORPORATION 1.16M $121.19M March 31, 2015
Jennison Associates 1.13M $88.11M Sept. 30, 2014
Franklin Resources 1.13M $117.58M March 31, 2015
Abingworth 1.11M $20.29M Dec. 31, 2012
BlackRock Advisors 1.10M $70.19M Sept. 30, 2013
BAILLIE GIFFORD & CO 1.09M $106.06M Dec. 31, 2014
Artisan Partners Limited Partnership 1.08M $113.25M March 31, 2015

Who sold Alnylam Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
Wells Fargo & Company March 31, 2014 1.17M $78.46M